Our Expertise
Specialized Knowledge Across Diverse Product Classes
At VJO Canada, our experts bring deep, years of hands-on experience across a broad spectrum of product development programs. From early-stage planning to regulatory strategy and commercialization, we provide the strategic insight and operational know-how to help you navigate the complex path to market.
We've been supporting biotechs and pharmaceutical companies developing:
- Vaccines – Regulatory strategy, preclinical-to-clinical transition, and global submission pathways
- Small Molecules – Comprehensive development and lifecycle planning for novel chemical entities (NCEs), generics, and hybrid products - See More
- Large Molecule Therapeutics / Biologics – Development and regulatory support for complex large molecules, including monoclonal antibodies, fusion proteins, biosimilars, and novel biologic entities - See More
- Rare & Orphan Indications – Strategic guidance for efficient development of therapies for underserved patient populations
- Cell & Gene Therapies – Expertise in CMC, regulatory interactions, and fast-track designations
- Medical Devices – Risk-based classification support, clinical evidence planning, and Health Canada/FDA submissions
- Diagnostics – Regulatory frameworks for IVDs, LDTs, and companion diagnostics
- Digital Health – Navigation of software-as-a-medical-device (SaMD), AI/ML products, and evolving digital regulations
- Medical Countermeasures (MCMs) – Specialized knowledge in emergency use, pandemic preparedness, and biodefense products
- Animal Health – Development and registration of veterinary products across species and jurisdictions
Our consultants are not just advisors—they become strategic partners, helping you align your product development strategy with regulatory expectations and market demands.
Therapeutic Experience
At VJO Canada, we specialize in guiding biotech companies through every stage of drug development, ensuring a streamlined path from concept to market.
Our therapeutic experience includes the following:
+ Cardiovascular Diseases
+ Rare Diseases
+ Dermatology
+ Endocrinology
+ Gastroenterology
+ Hepatology
+ Immunology
+ Infectious disease epidemiology
+ Metabolic
+ Nephrology
+ Oncology
+ Ophthalmology
+ Respiratory
+ Pediatrics
+ Rheumatology
Accelerating Your Drug Development Journey
